Skip to main content
. Author manuscript; available in PMC: 2022 Jun 14.
Published in final edited form as: J Alzheimers Dis. 2021;84(3):1079–1089. doi: 10.3233/JAD-210701

Figure 3. The process of ubiquitination following VPS35 silencing.

Figure 3.

A) Representative Western blot for Ubiquitin. Increased level of poly-ubiquitinated proteins levels following VPS35 silencing. B) Densitometric analysis of the immunoreactivity to Ubiquitin antibody (* p< 0.05 vs Ctr; ** p < 0.001 vs Ctr). All results are mean ± SEM (N=2 per groups, three individual experiments).